Physician profile
Robert J Thomas
NPI 1356314983
$35,598.20
in general payments reported to CMS, 2019-2025
9 companies · $1,717 in 2025
The $1,717 reported for 2025 was more than what 84% of Sleep Medicine (Internal Medicine) providers received nationally (typical 2025 total: $447).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2021: $11K · 2022: $13.29 · 2023: $82.00 · 2024: $9,572 · 2025: $1,717.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,302 · Food and Beverage: $945 · Travel and Lodging: $873 · Honoraria: $750 · Consulting Fee: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,302.00 |
| Food and Beverage | $945.27 |
| Travel and Lodging | $872.95 |
| Honoraria | $750.00 |
| Consulting Fee | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $30,356.93 | 2019-2025 | |
| Harmony Biosciences LLC | $2,800.00 | 2021 | |
| Zoll Respicardia, INC. | $1,167.38 | 2019-2025 | Remede System |
| Allergan, INC. | $500.00 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $500.00 | 2025 | |
| Itamar Medical INC | $216.06 | 2022-2024 | Watchpatone |
| Avadel Cns Pharmaceuticals, LLC | $39.78 | 2024 | Lumryz |
| Lexicon Pharmaceuticals, INC. | $18.05 | 2023 | Inpefa |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.